Delivery Order SPE2DB25D7067-SPE2DB25FSWAR
- Not listed
- This federal contract award, valued at $2,462.95, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, and has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOVIPREP POWDER PACKETS. The contract has a completion date of February 29, 2024 and a potential value of $4,298.25. This contract is not a set-aside award. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,662.58 firm fixed-price delivery order is for the supply of MOVIPREP powder packets, with a performance period ending on May 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, with a ceiling value of $1,801.88 and a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of MOVIPREP Powder Packets. The $1,947.30 award does not have a set-aside designation and is part of an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This single...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561888482 MOVIPREP powder packets. As a prime contractor on an indefinite delivery/indefinite quantity contract vehicle, Amerisourcebergen will deliver the medical preparation products to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of the DLA's mission to provide logistics support to the Department of Defense. No set aside designation or...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,753.92 on September 9, 2025, with an ultimate completion date of September 10, 2025. This contract is a firm fixed price delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.93 to AmerisourceBergen Drug Corp for Plenvu Powder Packets 3S, a bowel preparation product used in medical procedures. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,854.00 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This contract is unset-aside and represents a child award under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,167.54 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a single transaction under the company's larger contract vehicle with DLA Troop Support Medical....
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSWARDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,233.66 for MOVIPREP powder packets. Awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, this non-set-aside contract represents a small-value procurement from DLA's broader medical supply operations. The delivery order is performed at the contractor's Conshohocken facility and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen's significant IDC vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a diverse range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contractor's federal portfolio demonstrates extensive experience fulfilling DLA medical procurement requirements through competitive award processes, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's versatility in managing transactions across varying values while maintaining firm fixed pricing under its prime vendor arrangement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/15/25 |